Pacific Biosciences of California (PACB) 8-K Results of Operations and Financial Condition

Exhibit 99.1

PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

Condensed Consolidated Balance Sheets

(Unaudited)

(in thousands except per share amounts)	March 31, 2013			December 31, 2012
Assets
Current assets
Cash and cash equivalents	$	53,038		$	46,540
Investments		59,267			54,040
Accounts receivable		2,009			2,822
Inventory, net		10,597			9,592
Prepaid expenses and other current assets		1,570			2,006
Total current assets		126,481			115,000
Property and equipment, net		12,779			14,329
Other long-term assets		514			354
Total assets	$	139,774		$	129,683
Liabilities and Stockholders’ Equity
Current liabilities
Accounts payable	$	3,011		$	2,988
Accrued expenses and other current liabilities		7,425			8,204
Deferred revenue, current		2,961			3,378
Facility financing obligation, current		182			173
Total current liabilities		13,579			14,743
Deferred revenue, non-current		794			800
Deferred rent and other long-term liabilities		1,895			2,145
Notes payable, non-current		12,851			—
Financing derivative		999			—
Facility financing obligation, non-current		2,565			2,613
Total liabilities		32,683			20,301
Stockholders’ equity
Preferred Stock, $0.001 par value: Authorized 50,000 shares; No shares issued or outstanding at March 31, 2013 and December 31, 2012		—			—
Common Stock and additional paid-in-capital, $0.001 par value: Authorized 1,000,000 shares; Issued and outstanding 60,824 shares at March 31, 2013 and 56,170 shares at December 31, 2012		664,204			645,372
Accumulated other comprehensive income		11			30
Accumulated deficit		(557,124	)		(536,020	)
Total stockholders’ equity		107,091			109,382
Total liabilities and stockholders’ equity	$	139,774		$	129,683